The Role of MicroRNAs in Podocytes

被引:1
|
作者
Shi, Shaolin [1 ]
Liu, Zhi-Hong [1 ]
机构
[1] Nanjing Univ, Sch Med, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Nanjing 210002, Jiangsu, Peoples R China
来源
PODOCYTOPATHY | 2014年 / 183卷
基金
中国国家自然科学基金;
关键词
INDUCED COLLAGEN EXPRESSION; TGF-BETA; DIABETIC-NEPHROPATHY; DOWN-REGULATION; RENAL FIBROSIS; APOPTOSIS; DELETION; TARGET; GLOMERULOSCLEROSIS; INHIBITION;
D O I
10.1159/000360121
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: MicroRNAs (miRNAs) are small non-coding RNA species approximately 22 nucleotides in length. MicroRNAs repress the translation of target mRNAs or degrade target mRNAs. Studies have shown that miRNAs are implicated in extensive cellular processes and are important in the pathophysiology of many cell types, including podocytes. Summary: The essential role for miRNAs in podocytes was first demonstrated by a targeted deletion of Dicer, the enzyme involved in miRNA biogenesis, in the podocytes of mice; this deletion resulted in proteinuria, podocyte injury, glomerulosclerosis, and renal failure in the mice. Further studies revealed the roles of several miRNAs in the process of podocyte injury, including dedifferentiation, adhesion disruption, and apoptosis. miRNAs also play essential roles in mesangial and endothelial cells, which are two glomerular cell types that interact with podocytes during the process of podocytopathy. Studies have also shown the roles of miRNAs in mediating the therapeutic effect of existing drugs on podocytopathies, including glucocorticoids and ACE inhibitors. Among the miRNAs in podocytes, the miR-30 family appears to be particularly important. Key Messages: miRNAs play critical roles in podocyte homeostasis and podocytopathies. Fully understanding their roles and the molecular mechanisms will improve the diagnosis and treatment of podocytopathies, but further efforts are required to achieve this understanding. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:235 / 244
页数:10
相关论文
共 50 条
  • [1] The Pathogenic Role of Notch Activation in Podocytes
    Niranjan, Thiruvur
    Murea, Mariana
    Susztak, Katalin
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2009, 111 (04): : E73 - E79
  • [2] The role of Notch signaling in kidney podocytes
    Asanuma, Katsuhiko
    Trejo, Juan Alejandro Oliva
    Tanaka, Eriko
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (01) : 1 - 6
  • [3] Essential Role of X-Box Binding Protein-1 during Endoplasmic Reticulum Stress in Podocytes
    Hassan, Hossam
    Tian, Xuefei
    Inoue, Kazunori
    Chai, Nathan
    Liu, Chang
    Soda, Keita
    Moeckel, Gilbert
    Tufro, Alda
    Lee, Ann-Hwee
    Somlo, Stefan
    Fedeles, Sorin
    Ishibe, Shuta
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (04): : 1055 - 1065
  • [4] The Role of microRNAs in Inflammation
    Das, Kaushik
    Rao, L. Vijaya Mohan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [5] The role of microRNAs in tumors
    Liu, Chuanxin
    ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (10) : 1169 - 1177
  • [6] Role of microRNAs in the development of hepatocellular carcinoma and drug resistance
    Tricoli, Lucas
    Niture, Suresh
    Chimeh, Uche
    Ressom, Habtom
    Kumar, Deepak
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2019, 24 : 382 - 391
  • [7] A Tight Control of Non-Canonical TGF-β Pathways and MicroRNAs Downregulates Nephronectin in Podocytes
    Sopel, Nina
    Ohs, Alexandra
    Schiffer, Mario
    Mueller-Deile, Janina
    CELLS, 2022, 11 (01)
  • [8] Role of repressed microRNAs in endometriosis
    Nasu, Kaei
    Aoyagi, Yoko
    Zhu, Ruofei
    Okamoto, Mamiko
    Yano, Mitsutake
    Kai, Kentaro
    Kawano, Yasushi
    MEDICAL MOLECULAR MORPHOLOGY, 2022, 55 (01) : 1 - 7
  • [9] The role of microRNAs in heart failure
    Wang, Hongjiang
    Cai, Jun
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (08): : 2019 - 2030
  • [10] The role of microRNAs in intrahepatic cholangiocarcinoma
    Li, Zheng
    Shen, Jianxiong
    Chan, Matthew T. V.
    Wu, William Ka Kei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (01) : 177 - 184